Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Expert Opinion on Pharmacotherapy
|
April 15, 2025
Emerging pharmacotherapies for the treatment of childhood nephrotic syndrome
Eloise Salmon, Howard Trachtman
Pediatric Nephrology (Berlin, Germany)
|
December 27, 2024
Comparing adolescent glomerular disease clinical outcomes to the clinical outcomes in childhood, young adult, and adult-onset glomerular disease in the CureGN database
Kelly Garrity, Nathaniel Putnam, Elaine S Kamil, et al.
Kidney360
|
July 18, 2022
The Health Economic Impact of Nephrotic Syndrome in the United States
Christine A Simon, Eloise Salmon, Hailey E Desmond, et al.
Journal of the American Society of Nephrology : JASN
|
January 21, 2026
Patient-Focused Drug Development in Kidney Disease: Including Fit-for-Purpose Outcomes in Trials
John Devin Peipert, Louise Oni, Olalekan Lee Aiyegbusi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 16, 2026
How much change is meaningful in global impression anchors? Evidence from five rare diseases
Courtney Hurt, Maja Kuharic, Somayeh Hashemi, et al.
Critical Care Explorations
|
March 14, 2020
Vecuronium- and Esmolol-Induced Pseudohypernatremia Due to Drug Interference With Ion-Selective Electrodes
Tracey G Polsky, Eloise Salmon, Sarah S Welsh, et al.
Glomerular Diseases
|
May 11, 2026
Clinical Outcome Assessment Endpoints in Nephrotic Syndrome Drug Development: Research Partner Feedback on Patient-Centered Trial Design
John Devin Peipert, Maja Kuharic, Noelle E Carlozzi, et al.
Glomerular Diseases
|
October 30, 2024
Preparation and Rationale for a Patient-Centered Clinical Outcome Assessment Set of Fluid Overload for Drug Development in Nephrotic Syndrome
Eloise Salmon, Noelle E Carlozzi, Jin-Shei Lai, et al.
Glomerular Diseases
|
February 13, 2024
FSGS Recurrence Collaboration: Report of a Symposium
Debbie S Gipson, Chia-Shi Wang, Eloise Salmon, et al.
Kidney International
|
February 26, 2026
Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome
Tiffany Tu, Alejandro Ochoa, Amika Sood, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Expert Opinion on Pharmacotherapy
|
April 15, 2025
Emerging pharmacotherapies for the treatment of childhood nephrotic syndrome
Eloise Salmon, Howard Trachtman
Pediatric Nephrology (Berlin, Germany)
|
December 27, 2024
Comparing adolescent glomerular disease clinical outcomes to the clinical outcomes in childhood, young adult, and adult-onset glomerular disease in the CureGN database
Kelly Garrity, Nathaniel Putnam, Elaine S Kamil, et al.
Kidney360
|
July 18, 2022
The Health Economic Impact of Nephrotic Syndrome in the United States
Christine A Simon, Eloise Salmon, Hailey E Desmond, et al.
Journal of the American Society of Nephrology : JASN
|
January 21, 2026
Patient-Focused Drug Development in Kidney Disease: Including Fit-for-Purpose Outcomes in Trials
John Devin Peipert, Louise Oni, Olalekan Lee Aiyegbusi, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 16, 2026
How much change is meaningful in global impression anchors? Evidence from five rare diseases
Courtney Hurt, Maja Kuharic, Somayeh Hashemi, et al.
Critical Care Explorations
|
March 14, 2020
Vecuronium- and Esmolol-Induced Pseudohypernatremia Due to Drug Interference With Ion-Selective Electrodes
Tracey G Polsky, Eloise Salmon, Sarah S Welsh, et al.
Glomerular Diseases
|
May 11, 2026
Clinical Outcome Assessment Endpoints in Nephrotic Syndrome Drug Development: Research Partner Feedback on Patient-Centered Trial Design
John Devin Peipert, Maja Kuharic, Noelle E Carlozzi, et al.
Glomerular Diseases
|
October 30, 2024
Preparation and Rationale for a Patient-Centered Clinical Outcome Assessment Set of Fluid Overload for Drug Development in Nephrotic Syndrome
Eloise Salmon, Noelle E Carlozzi, Jin-Shei Lai, et al.
Glomerular Diseases
|
February 13, 2024
FSGS Recurrence Collaboration: Report of a Symposium
Debbie S Gipson, Chia-Shi Wang, Eloise Salmon, et al.
Kidney International
|
February 26, 2026
Polygenic Risk Scores and HLA Class II Variants are Biomarkers of Corticosteroid Response in Childhood Nephrotic Syndrome
Tiffany Tu, Alejandro Ochoa, Amika Sood, et al.
Page
of 2